BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17309647)

  • 1. Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study.
    Choquette AC; Bouchard L; Houde A; Bouchard C; Pérusse L; Vohl MC
    Clin Genet; 2007 Mar; 71(3):245-53. PubMed ID: 17309647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Holzapfel C; Baumert J; Grallert H; Müller AM; Thorand B; Khuseyinova N; Herder C; Meisinger C; Hauner H; Wichmann HE; Koenig W; Illig T; Klopp N
    Eur J Endocrinol; 2008 Oct; 159(4):407-16. PubMed ID: 18593823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
    Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population.
    Gottlieb MG; Schwanke CH; Santos AF; Jobim PF; Müssel DP; da Cruz IB
    Genet Mol Res; 2005 Dec; 4(4):691-703. PubMed ID: 16475114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco smoking, estrogen receptor alpha gene variation and small low density lipoprotein level.
    Shearman AM; Demissie S; Cupples LA; Peter I; Schmid CH; Ordovas JM; Mendelsohn ME; Housman DE
    Hum Mol Genet; 2005 Aug; 14(16):2405-13. PubMed ID: 16014638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study.
    Robitaille J; Pérusse L; Bouchard C; Vohl MC
    Obesity (Silver Spring); 2007 Sep; 15(9):2336-47. PubMed ID: 17890503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.
    Morabia A; Cayanis E; Costanza MC; Ross BM; Flaherty MS; Alvin GB; Das K; Gilliam TC
    Hum Mol Genet; 2003 Nov; 12(21):2733-43. PubMed ID: 12966036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS).
    Ruchat SM; Girard M; Weisnagel SJ; Bouchard C; Vohl MC; Pérusse L
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1018-22. PubMed ID: 18518884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.
    Putt W; Palmen J; Nicaud V; Tregouet DA; Tahri-Daizadeh N; Flavell DM; Humphries SE; Talmud PJ;
    Hum Mol Genet; 2004 Aug; 13(15):1587-97. PubMed ID: 15175273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
    Fiegenbaum M; de Andrade FM; Hutz MH
    Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of OSBPL11 gene polymorphisms with cardiovascular disease risk factors in obesity.
    Bouchard L; Faucher G; Tchernof A; Deshaies Y; Marceau S; Lescelleur O; Biron S; Bouchard C; Pérusse L; Vohl MC
    Obesity (Silver Spring); 2009 Jul; 17(7):1466-72. PubMed ID: 19325544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
    Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.
    Naukkarinen J; Nilsson E; Koistinen HA; Söderlund S; Lyssenko V; Vaag A; Poulsen P; Groop L; Taskinen MR; Peltonen L
    Circ Cardiovasc Genet; 2009 Oct; 2(5):522-9. PubMed ID: 20031629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of hierarchical clustering techniques to the modeling of the geographic distribution of genetic polymorphisms associated with chronic inflammatory diseases in the Québec population.
    Madore AM; Houde L; Vézina H; Vohl MC; Pérusse L; Mior N; Connelly PW; Laberge C; Gaudet D; Laprise C
    Community Genet; 2007; 10(4):218-26. PubMed ID: 17895627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The association of apolipoprotein B gene polymorphism with cerebral infarction with positive family history and its effect on plasma lipid levels].
    Liu BQ; Zhang L; Yang QD; Liu YH; Hu ZY; Xu HW; DU XP; Xia J
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3332-6. PubMed ID: 19257963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
    Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
    Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin-4 receptor gene and physical activity in the Québec Family Study.
    Loos RJ; Rankinen T; Tremblay A; Pérusse L; Chagnon Y; Bouchard C
    Int J Obes (Lond); 2005 Apr; 29(4):420-8. PubMed ID: 15597110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.